Olanzapine Glenmark

Medicinal product

(Invented) name

Olanzapine Glenmark

Active substance (s)

Olanzapinas

Strength

2,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AH03, Olanzapine

Marketing authorisation holder

Glenmark Arzneimittel GmbH, Vokietija

Date of authorisation

2009-12-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Olanzapinas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
38814	52496	1052496	lizdinė plokštelė	N28		Receptinis	EU/1/09/587/001	Netiekiama	-	-	No	-	-
38815	52497	1052497	lizdinė plokštelė	N56		Receptinis	EU/1/09/587/002	Netiekiama	-	-	No	-	-
38816	52498	1052498	lizdinė plokštelė	N70		Receptinis	EU/1/09/587/003	Netiekiama	-	-	No	-	-
100857	86968	1086968	lizdinė plokštelė	N98		Receptinis	EU/1/09/587/020	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-12-03	Registruotas